Atria Wealth Solutions’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.24M Sell
4,500
-1,560
-26% -$424K 0.03% 565
2025
Q1
$1.61M Buy
6,060
+1,746
+40% +$431K 0.02% 713
2024
Q4
$1.02M Buy
4,314
+524
+14% +$120K 0.01% 914
2024
Q3
$836K Sell
3,790
-614
-14% -$127K 0.01% 991
2024
Q2
$866K Sell
4,404
-1,032
-19% -$213K 0.01% 955
2024
Q1
$1.17M Buy
5,436
+251
+5% +$52.7K 0.01% 844
2023
Q4
$1.11M Buy
5,185
+3
+0.1% +$640 0.01% 821
2023
Q3
$1.04M Sell
5,182
-270
-5% -$53.7K 0.01% 796
2023
Q2
$1.01M Sell
5,452
-42
-0.8% -$7.76K 0.01% 829
2023
Q1
$1.05M Sell
5,494
-123
-2% -$22.2K 0.02% 778
2022
Q4
$962K Sell
5,617
-340
-6% -$59.1K 0.02% 764
2022
Q3
$1.06M Buy
5,957
+19
+0.3% +$3.75K 0.02% 695
2022
Q2
$1.22M Sell
5,938
-987
-14% -$209K 0.02% 621
2022
Q1
$1.65M Buy
+6,925
New +$1.63M 0.03% 542

Other funds holding CME

Atria Wealth Solutions's CME Position: Q2 2025 in Review

Atria Wealth Solutions reduced its CME Group (CME) stake by 26% in Q2 2025, selling an estimated $424K and leaving 4,500 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #565.

Atria Wealth Solutions first reported a position in CME in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.65M in Q1 2022. 1,662 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • Atria Wealth Solutions held 4,500 shares of CME Group worth $1.24M as of Q2 2025.
  • Atria Wealth Solutions sold 1,560 CME Group shares in Q2 2025, an estimated $424K.
  • CME Group made up 0.03% of Atria Wealth Solutions's portfolio in Q2 2025, its #565 holding.
  • Atria Wealth Solutions first reported a position in CME Group in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's CME Group position peaked at $1.65M in Q1 2022.
  • 1,662 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.